Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 2, 2005, Pages 504-513

  De Salamanca, Amalia Enríquez ^a,c   Siemasko, Karyn F ^b   Diebold, Yolanda ^a   Calonge, Margarita ^a   Gao, Jianping ^b   Juárez Campo, Mónica ^a   Stern, Michael E ^b  

^a UNIVERSITY OF VALLADOLID   (Spain)

^b ALLERGAN INC   (United States)

^c UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CHOLERA TOXIN; GAMMA INTERFERON; HYDROCORTISONE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INFLAMMATION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RECEPTOR DENSITY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CONJUNCTIVA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITHELIUM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; INTERFERON TYPE II; MICROSCOPY, FLUORESCENCE; RATS; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, MUSCARINIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 13944274073     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0665     Document Type: Article

References (65)

1. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169:429-435.
2. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
3. Proud D, Sweet J, Stein P, et al. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol. 1990;85:896-905.
4. Gao J, Schwalb TA, Addeo JV, Ghosn CR, Stern ME. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical cyclosporine A therapy. Cornea. 1998;17:654-663.
5. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43:2609-2614.
6. Stern ME, Beuerman RW, Fox RI, et al. A unified theory of the role of the ocular surface in dry eye. Adv Exp Med Biol. 1998;438:643-651.
7. Zoukhri D, Kublin CL. Impaired neurotransmission in lacrimal and salivary glands of a murine model of Sjogren's syndrome. Adv Exp Med Biol. 2002;506:1023-1028.
8. Kovacs L, Torok T, Bari F, et al. Impaired microvascular response to cholinergic stimuli in primary Sjogren's syndrome. Ann Rheum Dis. 2000;59:48-53.
9. Bacman S, Pérez Leiros C, Sterin-Borda L, et al. Autoantibodies against lacrimal gland M3 muscarinic acetylcholine receptors in patients with primary Sjögren's syndrome. Invest Ophthalmol Vis Sci. 1998;39:151-156.
10. Humphreys-Beher MG, Peck AB. New concepts for the development of autoimmune exorinopathy derived from studies with the NOD mouse model. Arch Oral Biol. 1999;44:S21-S215.
11. Nietgen GW, Schmidt J, Hesse L, Hönemann CW, Durieux ME. Muscarinic receptor functioning and distribution in the eye: molecular basis and implications for clinical diagnosis and therapy. Eye. 1999;13:285-300.
12. Bylund DB, Iversen LJ, Matulka WJ, Chacko DM. Characterization of alpha-2D adrenergic receptor subtypes in bovine ocular tissue homogenates. J Pharmacol Exp Ther. 1997;281:1171-1177.
13. Bylund DB, Chacko DM. Characterization of α2 adrenergic receptor subtypes in human ocular tissue homogenates. Invest Ophthalmol Vis Sci. 1999;40:2299-2306.
14. Wikberg-Matsson A, Wikberg JE, Uhlen S. Characterization of alpha 2-adrenoceptor subtypes in the porcine eye: identification of alpha 2A-adrenoceptors in the choroid, ciliary body and iris and alpha2A- and alpha2C-adrenoceptors in the retina. Exp Eye Res. 1996;63:57-66.
15. Wikberg-Matsson A, Uhlén S, Wikberg JE. Characterization of α1-adrenoceptor subtypes in the eye. Exp Eye Res. 2000;70:51-60.
16. Matsuo T, Cynader MS. Localization of alpha-2 adrenergic receptors in the human eye. Ophthalmic Res. 1992;24:213-219.
17. Huang Y, Gil DW, Vancheeuwijck P, et al. Localization of α2-adrenergic receptor subtypes in the anterior segment of the human eye with selective antibodies. Invest Ophthalmol Vis Sci. 1995;36:2729-2739.
18. Elena PP, Denis P, Kosina-Boix M, Saraux H, Lapalus P. Beta adrenergic binding sites in the human eye: an autoradiographic study. J Ocul Pharmacol. 1990;6:143-149.
19. Schmitt CJ, Gross DM, Share NN. Beta-adrenergic receptor subtypes in iris-ciliary body of rabbits. Graefes Arch Clin Exp Ophthalmol. 1984;221:167-170.
20. Lind GJ, Cavanagh HD. Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest Ophthalmol Vis Sci. 1993;34:2943-2952.
21. Ríos JD, Zoukhri D, Rawe IM, Hodges RR, Zieske JD, Dart DA. Immunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. Invest Ophthalmol Vis Sci. 1999;40:1102-1111.
22. Diebold Y, Ríos JD, Hodges RR, Rawe I, Dartt DA. Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci. 2001;42:2270-2282.
23. Duke-Elder S, Wybar KC. The Anatomy of the Visual System. London: Henry Kimpton, 1961:541-558. System of Ophthalmology; Vol 2.
24. Duke-Elder S, Wybar KC. The Anatomy of the Visual System. London: Henry Kimpton, 1961:541-558. System of Ophthalmology; Vol 2.
25. Ruskell GL. Innervation of the conjunctiva. Trans Ophthalmol Soc UK. 1985;104:390-395.
26. Dartt DA, McCarthy DM, Mercer HJ, Kessler TL, Chung EH, Zieske JD. Localization of nerves adjacent to goblet cells in rat conjunctiva. Curr Eye Res. 1995;14:993-1000.
27. Ríos JD, Forde K, Diebold Y, Lightman J, Zieske JD, Dartt DA. Development of conjunctival goblet cells and their neuroreceptor subtype expression. Invest Ophthalmol Vis Sci. 2000;41:2127-2137.
28. Kessler TL, Mercer HJ, Zieske JD, McCarthy DM, Dartt DA. Stimulation of goblet cell mucous secretion by activation of nerves in rat conjunctiva. Curr Eye Res. 1995;14:985-992.
29. Dartt DA, Kessler TL, Chung EH, Zieske JD. Vasoactive intestinal peptide-stimulated glycoconjugate secretion from conjunctival goblet cells. Exp Eye Res. 1996;63:27-34.
30. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002;21:555-576.
31. Diebold Y, Calonge M, Enríquez de Salamanca A, et al. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva. Invest Ophthalmol Vis Sci. 2003;44:4263-4274.
32. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
33. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA. 1979;76:4350-4354.
34. Sharif NA, Crider JY, Griffin BW, Davis TL, Howe WE. Pharmacological analysis of mast cell mediator and neurotransmitter receptors coupled to adenylate cyclase and phospholipase C on immunocytochemically-defined human conjunctival epithelial cells. J Ocul Pharmacol Ther. 1997;13:321-336.
35. Chang DJ, Chang TK, Yamanishi SS, et al. Molecular cloning, genomic characterization and expression of novel human α1A-adrenoceptor isoforms. FEBS Lett. 1998;422:279-283.
36. Hirasawa A, Shibata K, Horie K, et al. Cloning, functional expression and tissue distribution of human alpha 1c-adrenoceptor splice variants. FEBS Lett. 1995;363:256-260.
37. Hutchinson DS, Bengtsson T, Evans BA, Summers RJ. Mouse beta 3a- and beta 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilize distinct signalling pathways. Br J Pharmacol. 2002;135:1903-1914.
38. Hebert TE, Moffett S, Morello JP, et al. A peptide derived from a beta 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem. 1996;271:16384-16392.
39. Gomperts BD, Kramer IM, Tatham PER. Receptors. Signal Transduction. London. Academic Press; 2002:33-69.
40. Bernard V, Brana C, Liste I, Lockridge O, Bloch B. Dramatic depletion of cell surface M2 muscarinic receptor due to limited delivery from intracytoplasmic stores in neurons of acetylcholinesterase-deficient mice. Mol Cell Neurosci. 2003;23:121-133.
41. Bernard V, Levey AI, Bloch B. Regulation of the subcellular distribution of M4 muscarinic acetylcholine receptors in striatal neurons in vivo by the cholinergic environment: evidence for regulation of cell surface receptors by endogenous and exogenous stimulation. J Neurosci. 1999;19:10237-10249.
42. Mackenzie JF, Daly CJ, Pediani JD, McGrath JC. Quantitative imaging in live human cells reveals intracellular α(1)-adrenoceptor ligand-binding sites. J Pharmacol Exp Ther. 2000;294:434-443.
43. Hrometz SL, Edelmann SE, McCune DF, et al. Expression of multiple α1 adrenoceptor on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther. 1999;290:452-463.
44. Hirasawa A, Sugawara T, Awaji T, Tsumaya K, Ito H, Tsujimoto G. Subtype-specific differences in subcellular location of α1-adrenoceptors: chloroethylclonidine preferentially alkylates the accessible surface α1-adrenoceptors irrespective of subtype. Mol Pharmacol. 1997;52:764-770.
45. McCune DF, Edelmann SE, Olges JR, et al. Regulation of the cellular localization and signaling properties of the α(1B)- and α(1D)-adrenoceptors by agonists and inverse agonists. Mol Pharmacol. 2000;57:659-666.
46. von Zastrow M, Link R, Daunt D, Barsh G, Kobilka B. Subtype-specific differences in the intracellular sorting of G protein-coupled receptors. J Biol Chem. 1993;268:763-766.
47. Wozniak M, Limbird LE. The three alpha 2-adrenergic receptor subtypes achieve basolateral localization in Madin-Darby canine kidney II cells via different targeting mechanisms. J Biol Chem. 1996;271:5017-5024.
48. Daunt DA, Hurt C, Hein L, KaIlio J, Feng F, Kobilka BK. Subtype-specific intracellular trafficking of alpha2-adrenergic receptors. Mol Pharmacol. 1997;51:711-720.
49. 2C-adrenoceptor: evidence for the organization of receptor microdomains during neural differentiation of PC12 cells. J Biol Chem. 2000;275:35424-35431.
50. Olli-Lähdesmäki T, Kallio J, Scheinin M. Receptor subtype-induced targeting and subtype-specific internalization of human α2-adrenoceptors in PC12 cells. J Neurosci. 1999;19:9281-9288.
51. Pimplikar SW, Simons K. Role of heterotrimeric G proteins in polarized membrane transport. J Cell Sci. 1993;17:27-32.
52. Zeng F-Y, Soldner A, Schöneberg T, Wess J. Conserved extracellular cysteine pair in the M3 muscarinic acetylcholine receptor is essential for the proper receptor cell surface localization but not for G protein coupling. J Neurochem. 1999;72:2404-2414.
53. Ludwig A, Ehlert JE, Flad H-D, Brandt E. Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression. J Immunol. 2000;165:1044-1052.
54. 2C-adrenoceptors from Golgi to plasma membrane in transfected human embryonic kidney 293 cells. Mol Pharmacol. 2001;60:1195-1200.
55. Baudouin C. The pathology of dry eye. Surv Ophthalmol. 2001;45:S211-S220.
56. Gamache DA, Dimitrijevich SD, Weimer LK, et al. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocul Immunol Inflamm. 1997;5:117-128.
57. Jones DT, Monroy D, Ji Z, Therton SS, Pflugfelder SC. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelial epithelium. Invest Ophthalmol Vis Sci. 1994;35:3493-3504.
58. Ramer-Quinn DS, Baker RA, Sanders VM. Activated T-helper 1 and T helper 2 cells differentially express the β2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. J Immunol. 1997;159:4857-4867.
59. Kohm AP, Sanders VM. Suppression of antigen-specific Th2 cell-dependent IgM and IgG1 production following norepinephrine depletion in vivo. J Immunol. 1999;162:5299-5308.
60. Spengler RN, Chensue SW, Giacherio DA, Blenk N, Kunkel SL. Endogenous norepinephrine regulates tumor necrosis factor-α production from macrophages in vitro. J Immunol. 1994;152:3024-3031.
61. Nomura J, Hosoi T, Okuma Y, Nomura Y. The presence and functions of muscarinic receptors in human T cells: the involvement in IL-2 and IL-2 receptor system. Life Sci. 2003;72:2121-2126.
62. Tayebati SK, El-Assouad D, Ricci A, Amenta F. Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. J Neuroimmunol. 2002;132:147-155.
63. Kawashima K, Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 2003;74:675-696.
64. Heijnen CJ, Rouppe van der Voort C, van de Pol M, Kavelaars A. Cytokines regulate alpha(1)-adrenergic receptor mRNA expression in human monocytic cells and endothelial cells. J Neuroimmunol. 2002;125:66-72.
65. Heijnen CJ, Rouppe van der Voort C, Wulffraat N, van der Net J, Kuis W, Kavelaars A. Functional alpha 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J Neuroimmunol. 1996;71:223-226.